The beginning of the end of warfarin?

Med J Aust. 2004 Jun 7;180(11):549-51. doi: 10.5694/j.1326-5377.2004.tb06088.x.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use
  • Aspirin / pharmacology
  • Azetidines / economics
  • Azetidines / pharmacokinetics
  • Azetidines / therapeutic use*
  • Benzylamines
  • Glycine / analogs & derivatives*
  • Glycine / pharmacokinetics
  • Glycine / therapeutic use*
  • Humans
  • Platelet Aggregation Inhibitors / pharmacology
  • Prodrugs / economics
  • Prodrugs / pharmacokinetics
  • Prodrugs / therapeutic use*
  • Thrombin / antagonists & inhibitors*
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Azetidines
  • Benzylamines
  • Platelet Aggregation Inhibitors
  • Prodrugs
  • melagatran
  • ximelagatran
  • Warfarin
  • Thrombin
  • Aspirin
  • Glycine